+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Diagnostics in Infectious Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Molecular Diagnostics in Infectious Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Molecular Diagnostics in Infectious Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 271 Pages
  • July 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5925051
Description Jump to:
The global Molecular Diagnostics in Infectious Disease Testing Market is poised for robust expansion over the forecast period, with an expected valuation of US$ 67 Bn in 2025. The market is projected to reach US$ 95 Bn by 2032, expanding at a CAGR of 5.11% between 2025 and 2032. Driven by growing infectious disease prevalence and demand for rapid, accurate diagnostics, the market continues to witness technological advancements, increasing healthcare spending, and favorable government initiatives that support early detection and management.

Molecular Diagnostics in Infectious Disease Testing Market - Report Scope:

The molecular diagnostics in infectious disease testing market comprises a suite of tools and technologies that detect genetic material from pathogens, enabling early and precise disease identification. Key applications include the diagnosis of HIV/AIDS, tuberculosis, hepatitis, and hospital-acquired infections, among others. Molecular testing methods such as PCR, NGS, and INAAT provide speed and accuracy unmatched by traditional diagnostics. With a rising global burden of infectious diseases and increasing focus on precision medicine, molecular diagnostics are being rapidly integrated into both clinical and point-of-care settings.

Key Market Drivers:

The market is experiencing strong growth due to the surging incidence of infectious diseases globally, particularly in densely populated and low-resource regions. Increased awareness about early disease detection and a growing preference for molecular diagnostic techniques, which offer high specificity and sensitivity, are fueling adoption. Advancements in molecular platforms, such as real-time PCR and next-generation sequencing, are enabling multiplex testing for multiple pathogens in a single assay. Government support through funding and favorable regulatory policies for diagnostics development further accelerates market growth. Additionally, pandemics like COVID-19 have highlighted the importance of rapid molecular testing, reshaping diagnostics infrastructure worldwide.

Market Restraints:

Despite its promising trajectory, the market faces challenges such as high costs of molecular diagnostic instruments and reagents, which can limit accessibility in low-income settings. Additionally, the complexity of these technologies requires specialized personnel and infrastructure, posing hurdles in rural and underdeveloped regions. Regulatory hurdles and variable reimbursement policies across countries also affect the widespread adoption of molecular diagnostics. Moreover, the need for constant calibration, maintenance, and data interpretation can act as deterrents for smaller labs and clinics.

Emerging Business Opportunities:

The market presents multiple growth opportunities fueled by the increasing penetration of portable and user-friendly molecular testing platforms, especially for point-of-care and home diagnostics. Emerging economies in Asia Pacific and Latin America are experiencing rapid healthcare modernization, offering vast untapped potential. Partnerships between public health organizations and diagnostic firms to develop disease-specific tests for outbreaks such as dengue, Zika, and Ebola further support innovation. The integration of AI in molecular diagnostics for automated result analysis and predictive diagnostics is another lucrative frontier. Additionally, expanding applications beyond infectious diseases into oncology and genetic screening add to future growth prospects.

Regional Outlook:

North America dominates the global market due to high diagnostic awareness, advanced healthcare infrastructure, and substantial R&D investments. Europe follows closely with strong government support for early disease detection and pandemic preparedness. The Asia Pacific region is expected to exhibit the fastest growth, driven by the increasing disease burden, urbanization, and growing diagnostic lab networks in countries like India and China. Latin America and the Middle East & Africa are emerging as high-potential markets with increasing healthcare investments and expanding access to diagnostic services.

Leading Companies:

Key players in the global Molecular Diagnostics in Infectious Disease Testing Market are focusing on technological advancements, regulatory approvals, and strategic collaborations to enhance their product offerings. Leading companies include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens AG
  • Veridex, LLC
  • Luminex Corp.
  • GenMark Diagnostics, Inc.
  • Qiagen N.V.
  • Genomix Biotech
  • bioTheranostics
These companies are investing in automation, multiplex assay development, and portable diagnostic kits to strengthen their market position and expand their reach globally.

Market Segmentation:

By Product:

  • Instruments and Analyzers
  • Assays and Reagents
  • Services and Software

By Application:

  • Hepatitis B
  • Hepatitis C
  • AIDS
  • Tuberculosis
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
  • Hospital-Acquired Infections
  • Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • Human Papillomavirus (HPV) Infection
  • Others

By Technique:

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microarrays
  • Next-Generation Sequencing (NGS)
  • Hybridization
  • Others

By End User:

  • Hospitals
  • Private Labs
  • Clinics
  • Academic Institutes
  • Laboratories
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Molecular Diagnostics in Infectious Disease Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2024
3.1. Global Molecular Diagnostics in Infectious Disease Testing Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2024
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2024
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019-2024
4.2. Prominent Factor Affecting Molecular Diagnostics in Infectious Disease Testing Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
5.1. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Instruments and Analyzers
5.1.1.2. Assays and Reagents
5.1.1.3. Services and Software
5.2. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Hepatitis B
5.2.1.2. Hepatitis C
5.2.1.3. AIDS
5.2.1.4. Tuberculosis
5.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
5.2.1.6. Hospital-Acquired Infections
5.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
5.2.1.8. Human Papillomavirus (HPV) Infection
5.2.1.9. Others
5.3. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Polymerase Chain Reaction (PCR)
5.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3.1.3. Microarrays
5.3.1.4. Next-Generation Sequencing (NGS)
5.3.1.5. Hybridization
5.3.1.6. Others
5.4. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Private Labs
5.4.1.3. Clinics
5.4.1.4. Academic Institutes
5.4.1.5. Laboratories
5.4.1.6. Others
5.5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
6.1. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Instruments and Analyzers
6.1.1.2. Assays and Reagents
6.1.1.3. Services and Software
6.2. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Hepatitis B
6.2.1.2. Hepatitis C
6.2.1.3. AIDS
6.2.1.4. Tuberculosis
6.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.1.6. Hospital-Acquired Infections
6.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.1.8. Human Papillomavirus (HPV) Infection
6.2.1.9. Others
6.3. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Polymerase Chain Reaction (PCR)
6.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3.1.3. Microarrays
6.3.1.4. Next-Generation Sequencing (NGS)
6.3.1.5. Hybridization
6.3.1.6. Others
6.4. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Private Labs
6.4.1.3. Clinics
6.4.1.4. Academic Institutes
6.4.1.5. Laboratories
6.4.1.6. Others
6.5. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1. Key Highlights
6.5.1.1. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.3. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.4. U.S. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.5. Canada Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.6. Canada Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.7. Canada Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.8. Canada Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
7.1. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Instruments and Analyzers
7.1.1.2. Assays and Reagents
7.1.1.3. Services and Software
7.2. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Hepatitis B
7.2.1.2. Hepatitis C
7.2.1.3. AIDS
7.2.1.4. Tuberculosis
7.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
7.2.1.6. Hospital-Acquired Infections
7.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
7.2.1.8. Human Papillomavirus (HPV) Infection
7.2.1.9. Others
7.3. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Polymerase Chain Reaction (PCR)
7.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.3.1.3. Microarrays
7.3.1.4. Next-Generation Sequencing (NGS)
7.3.1.5. Hybridization
7.3.1.6. Others
7.4. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Private Labs
7.4.1.3. Clinics
7.4.1.4. Academic Institutes
7.4.1.5. Laboratories
7.4.1.6. Others
7.5. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Germany Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.2. Germany Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.3. Germany Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.4. Germany Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.5. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.6. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.7. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.9. France Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.10. France Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.11. France Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.12. France Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.13. Italy Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.14. Italy Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.15. Italy Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.16. Italy Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.17. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.18. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.19. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.20. Turkey Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.21. Russia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.22. Russia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.23. Russia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.24. Russia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.25. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.26. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.27. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.28. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
8.1. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Instruments and Analyzers
8.1.1.2. Assays and Reagents
8.1.1.3. Services and Software
8.2. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Hepatitis B
8.2.1.2. Hepatitis C
8.2.1.3. AIDS
8.2.1.4. Tuberculosis
8.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
8.2.1.6. Hospital-Acquired Infections
8.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
8.2.1.8. Human Papillomavirus (HPV) Infection
8.2.1.9. Others
8.3. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Polymerase Chain Reaction (PCR)
8.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.1.3. Microarrays
8.3.1.4. Next-Generation Sequencing (NGS)
8.3.1.5. Hybridization
8.3.1.6. Others
8.4. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Private Labs
8.4.1.3. Clinics
8.4.1.4. Academic Institutes
8.4.1.5. Laboratories
8.4.1.6. Others
8.5. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1. Key Highlights
8.5.1.1. China Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.2. China Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.3. China Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.4. China Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.5. Japan Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.6. Japan Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.7. Japan Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.8. Japan Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.9. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.10. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.11. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.12. South Korea Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.13. India Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.14. India Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.15. India Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.16. India Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.17. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.18. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.19. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.20. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.21. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.22. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.23. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.24. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
9.1. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. Instruments and Analyzers
9.1.1.2. Assays and Reagents
9.1.1.3. Services and Software
9.2. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.2.1. Key Highlights
9.2.1.1. Hepatitis B
9.2.1.2. Hepatitis C
9.2.1.3. AIDS
9.2.1.4. Tuberculosis
9.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
9.2.1.6. Hospital-Acquired Infections
9.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
9.2.1.8. Human Papillomavirus (HPV) Infection
9.2.1.9. Others
9.3. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Polymerase Chain Reaction (PCR)
9.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3.1.3. Microarrays
9.3.1.4. Next-Generation Sequencing (NGS)
9.3.1.5. Hybridization
9.3.1.6. Others
9.4. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Private Labs
9.4.1.3. Clinics
9.4.1.4. Academic Institutes
9.4.1.5. Laboratories
9.4.1.6. Others
9.5. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1. Key Highlights
9.5.1.1. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.2. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.3. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.4. Brazil Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.5. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.6. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.7. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.8. Mexico Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.9. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.10. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.11. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.12. Argentina Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.13. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.14. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.15. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.16. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
10.1. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.1.1. Key Highlights
10.1.1.1. Instruments and Analyzers
10.1.1.2. Assays and Reagents
10.1.1.3. Services and Software
10.2. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.2.1. Key Highlights
10.2.1.1. Hepatitis B
10.2.1.2. Hepatitis C
10.2.1.3. AIDS
10.2.1.4. Tuberculosis
10.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
10.2.1.6. Hospital-Acquired Infections
10.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
10.2.1.8. Human Papillomavirus (HPV) Infection
10.2.1.9. Others
10.3. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.3.1. Key Highlights
10.3.1.1. Polymerase Chain Reaction (PCR)
10.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.3.1.3. Microarrays
10.3.1.4. Next-Generation Sequencing (NGS)
10.3.1.5. Hybridization
10.3.1.6. Others
10.4. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Private Labs
10.4.1.3. Clinics
10.4.1.4. Academic Institutes
10.4.1.5. Laboratories
10.4.1.6. Others
10.5. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1. Key Highlights
10.5.1.1. GCC Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.2. GCC Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.3. GCC Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.4. GCC Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.5. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.6. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.7. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.8. South Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.9. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.10. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.11. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.12. Egypt Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.13. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.14. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.15. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.16. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.17. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.18. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.19. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.20. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Technique vs Application Heatmap
11.2. Company Market Share Analysis, 2025
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Abbott Laboratories
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Becton
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Dickinson and Company
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. bioMérieux
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Thermo Fisher Scientific Inc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. F. Hoffmann-La Roche Ltd
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Siemens AG
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Veridex, LLC
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Luminex Corp.
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. GenMark Diagnostics, Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Qiagen N.V.
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Genomix Biotech
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
11.4.13. bioTheranostics
11.4.13.1. Company Overview
11.4.13.2. Product Portfolio
11.4.13.3. Financial Overview
11.4.13.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • bioMérieux
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens AG
  • Veridex, LLC
  • Luminex Corp.
  • GenMark Diagnostics, Inc.
  • Qiagen N.V.
  • Genomix Biotech
  • bi

Related Topics

Related Reports

Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 247 Pages
  • Global
From
DNA and RNA Sample Preparation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

DNA and RNA Sample Preparation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 209 Pages
  • Global
From
Molecular Diagnostics - Product Image

Molecular Diagnostics

  • Newsletter
  • 100 Pages
  • Global
Infectious Disease Molecular Diagnostics Market Report and Forecast 2024-2032 - Product Image

Infectious Disease Molecular Diagnostics Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Enteric Disease Testing Market Report by Product Type, Technique, Disease Type, End User, and Region 2024-2032 - Product Image

Enteric Disease Testing Market Report by Product Type, Technique, Disease Type, End User, and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.